OTCM
SEMHF
Market cap52bUSD
, Last price
Name
Siemens Healthineers AG
Chart & performance
P/E
—
P/S
—
EPS
1.92
Vol. 1Y
—
Shs. 5Y
2.30%
Rev. 5Y
10.08%
Div Yld LY
—
Div Yld TTM
—
Revenues
23.38b
+4.53%
Net income
2.14b
+10.40%
CFO
3.08b
+24.87%
Dividend
Feb 06, 20261.16431 /sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Siemens Healthineers AG, along with its affiliated companies, offers a global portfolio of diagnostic and therapeutic solutions, which it designs, produces, and markets to healthcare organizations worldwide. The company's operations are structured into four distinct divisions: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging division specializes in advanced medical imaging technologies, encompassing magnetic resonance imaging (MRI), computed tomography (CT), X-ray equipment, molecular imaging techniques, and ultrasound systems. Within the Diagnostics division, the focus is on supplying in-vitro diagnostic solutions and services to healthcare professionals across various settings, including laboratory, molecular, and point-of-care environments. It also delivers laboratory workflow optimization tools and informatics solutions. The Varian segment is dedicated to oncology, furnishing cancer care technologies, comprehensive solutions, and support services to hospital and clinic oncology departments. This includes advanced workflow optimization through technology, expert clinical services and consultancy, as well as digital tools and applications designed to streamline and oversee patient treatment and therapy protocols. The Advanced Therapies division delivers products engineered to facilitate image-guided, minimally invasive procedures in fields such as cardiology, interventional radiology, and surgery. Its offerings extend to angiography systems and mobile C-arms, notably featuring a robotic-assisted platform for endovascular interventions involving coronary and peripheral vasculature. Beyond these core segments, Siemens Healthineers also offers a suite of supplementary services. These comprise managing equipment performance, clinical training and e-learning programs, asset management, and outsourced departmental services for both laboratories and wider healthcare institutions, alongside consulting and digital health solutions. Headquartered in Erlangen, Germany, Siemens Healthineers AG functions as a subsidiary of Siemens Aktiengesellschaft.
Related entities
Parent
Subsidiaries (87)
(ju)belianmedikeolsiseutemjeukolia
Acuson (Shanghai) Co., Ltd.
Acuson France SAS
ACUSON ITALY S.R.L.
Acuson Osterreich GmbH
AMERICAN INSTITUTE OF PATHOLOGY AND LABORATORY SCIENCES PRIVATE LIMITED
ARTMED HEALTHCARE PRIVATE LIMITED
BLOCK IMAGING PARTS & SERVICE, LLC
CANCER TREATMENT SERVICES HYDERABAD PRIVATE LIMITED
CTSI (Mauritius), Ltd
D3 ONCOLOGY INC.
EPOCAL INC.
fang zhi jian kang guan li gu fen you xian gong si
Hangzhou Alicon Pharm Sci & Tec Co., Ltd.
hong tai jian kang guan li gu wen gu fen you xian gong si
J Restrepo Equiphos SAS
MANSFIELD INSURANCE COMPANY
P.E.T.NET HOUSTON, LLC
PAGE MILL CORPORATION
PETNET INDIANA, LLC
Key people
Darleen Caron
Chief Human Resource Officer, Member of the Managing Board · since 2021
Bernhard Montag
Chief Executive Officer, Member of the Management Board · since 2022
Jochen Schmitz
Chief Financial Officer, Member of the Managing Board · since 2017
Elisabeth Staudinger-Leibrecht
Member of the Management Board · since 2021
Deputy Chairwoman of the Supervisory Board - Employee Representative · since 2024
Chairman of the Supervisory Board · since 2020
Independent Member of the Supervisory Board · since 2018
Independent Vice Chairman the Supervisory Board · since 2023
Independent Member of the Supervisory Board · since 2023
Member of the Supervisory Board - Employee Representative · since 2024
Member of the Supervisory Board · since 2023
Stephan Buettner
Member of the Supervisory Board - Employee Representative · since 2024
Member of the Supervisory Board · since 2020
Lars-Christian Dinglinger
Member of the Supervisory Board - Employee Representative · since 2024
Member of the Supervisory Board - Employee Representative · since 2024
Nick Heindl
Member of the Supervisory Board - Employee Representative · since 2024
Peter Koerte
Member of the Supervisory Board · since 2023
Volker Lang
Member of the Supervisory Board - Employee Representative · since 2025
Sarena Lin
Independent Member of the Supervisory Board · since 2023
Axel Patze
Member of the Supervisory Board - Employee Representative · since 2024
IPO date
Mar 16, 2018
Employees
70,800
Domiciled in
DE
Incorporated in
DE
Legal address
n.a
München, BY 80331
DE
München, BY 80331
DE
Headquarters
Siemensstr. 3
Forchheim, BY 91301
DE
Forchheim, BY 91301
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||